Friday, July 31, 2026

China-North Korea ‘Anti-US Alliance’ Now Official? Beijing Vows Support in Tariff Wars

China strengthens ties with North Korea after a summit, emphasizing friendship and cooperation during a reception for China's National Day.

How Will New Regulations Simplify North-South Trade? A Deep Dive into Food Import Procedures

South Korea simplifies import procedures for North Korean food products to enhance inter-Korean trade and ensure food safety standards.

How the Cheongung-II Missile Intercepted 100% of Iranian Cruise Missiles: A Game Changer in Modern Warfare?

Rep. Yoo Yong-won discusses the worsening Ukraine war, U.S.-Iran conflict, and implications for global security and defense strategies.

Tag: Medipost

CARTISTEM vs. Traditional Treatments: What Makes Medipost’s Stem Cell Therapy a Game-Changer?

Medipost to commercialize CARTISTEM in Japan using domestically produced media, enhancing supply chain stability and competitiveness.

Medipost Reports Positive Phase 3 Results for CARTISTEM in Japan’s Knee Osteoarthritis Trial

Medipost's CARTISTEM therapy shows significant efficacy in Phase 3 trials for knee osteoarthritis in Japan, enhancing global competitiveness.

Medipost’s CARTISTEM® Completes Phase 3 Trials in Japan: What This Means for Knee Osteoarthritis Treatment

Medipost completes Phase 3 trial for CARTISTEM in Japan, targeting knee osteoarthritis treatment and planning U.S. trial enrollment soon.

Medipost’s Cartistem: Achieving 3000 Knee Cartilage Restoration Surgeries – A Game Changer for Osteoarthritis Treatment

Medipost's Cartistem therapy reaches 3,000 procedures for cartilage restoration, proving its safety and efficacy for knee osteoarthritis.

U.S. Surgeons Get Hands-On With Korea’s Game-Changing Stem Cell Therapy

Medipost's Cartistem® training program for U.S. orthopedic specialists enhances global collaboration and prepares for Phase 3 trials.

Top News

- Our Sponsors Ad -

Follow us